| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 04/26/2001 | WO2001029219A1 Human cub-domain-containing protein and gene encoding the same |
| 04/26/2001 | WO2001029056A1 Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 04/26/2001 | WO2001029044A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 04/26/2001 | WO2001029042A1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 04/26/2001 | WO2001029028A1 9- (piperazinylalkyl) carbazoles as bax-modulators |
| 04/26/2001 | WO2001029022A1 Benzopyran derivatives |
| 04/26/2001 | WO2001029015A2 Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists |
| 04/26/2001 | WO2001029007A1 Pyrazole derivatives as cannabinoid receptor antagonists |
| 04/26/2001 | WO2001028978A1 Bicyclic amino acids as pharmaceutical agents |
| 04/26/2001 | WO2001028585A1 Novel process for making human papillomavirus virus-like particles with improved properties |
| 04/26/2001 | WO2001028516A2 Sustained-release formulations for treating cns-mediated disorders |
| 04/26/2001 | WO2001028515A1 Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion |
| 04/26/2001 | WO2001028497A2 Novel bicyclic cannabinoid agonists for the cannabinoid receptor |
| 04/26/2001 | WO2000077040A3 Human intracellular signaling molecules |
| 04/26/2001 | WO2000059447A3 Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding |
| 04/26/2001 | WO1997035591B1 Method of treating ciliary dyskinesia with uridine triphosphates and related compounds |
| 04/26/2001 | CA2388503A1 Novel bicyclic cannabinoid agonists for the cannabinoid receptor |
| 04/26/2001 | CA2388450A1 Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 04/26/2001 | CA2388421A1 Human cub-domain-containing protein and gene encoding the same |
| 04/26/2001 | CA2387892A1 Pyrazole derivatives as cannabinoid receptor antagonists |
| 04/26/2001 | CA2387819A1 Sustained-release formulations for treating cns-mediated disorders |
| 04/26/2001 | CA2386942A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 04/26/2001 | CA2386922A1 Novel polypeptides and polynucleotides encoding same |
| 04/26/2001 | CA2386422A1 Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion |
| 04/26/2001 | CA2385472A1 Isoxazolecarboxamide derivatives |
| 04/26/2001 | CA2384844A1 Novel process for making human papillomavirus virus-like particles with improved properties |
| 04/25/2001 | EP1094075A1 Human G-protein coupled receptor |
| 04/25/2001 | EP1094063A1 9-(Piperazinylalkyl)carbazoles as Bax-modulators |
| 04/25/2001 | EP1093816A2 Use of ST1435 in hormonal therapy by transdermal application |
| 04/25/2001 | EP1093521A2 Human transferases |
| 04/25/2001 | EP1093362A1 Treatment of anti-estrogen resistant breast cancer using rxr modulators |
| 04/25/2001 | EP1093361A1 Plaster which contains steroids, and a method for the production and use thereof |
| 04/25/2001 | EP0804176B1 Transdermal presentation of nitroglycerin for preventing undesired labour |
| 04/25/2001 | CN1292702A Newcontraceptive kit for monotherapy |
| 04/25/2001 | CN1292691A Preparation for treatment of erectile dysfunction |
| 04/25/2001 | CN1292291A Tiaojing Baokang pill made up by using several natural Chinese medicinal materials |
| 04/25/2001 | CN1292290A Uterus-warming pregnancy-helping pill madu up by using several natural Chinese medicinal materials |
| 04/25/2001 | CN1292289A Guilu essence-incressing yang-strengthening pill made up by using several natural Chinese medicines |
| 04/25/2001 | CN1292279A Medicine for curing emmeniopathy and its preparation method |
| 04/25/2001 | CN1292275A Chinese medicine preparation for curing postpartum disease of woman |
| 04/25/2001 | CN1292270A Kidney-reinforcing yang-strengthening liquor and its preparation method |
| 04/25/2001 | CN1292264A Phosphodiesterase inhibitor and its use |
| 04/25/2001 | CN1064954C Orthosubstituted benzoylguanidine, preparation of same, pharmaceutical containing same and application of same |
| 04/24/2001 | US6221909 Administering to the cow the isopropyl ester of the hydroxy analogue of methionine. |
| 04/24/2001 | US6221891 Crystal form of N-(4-triflouromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 04/24/2001 | US6221881 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 04/24/2001 | US6221879 8-azabicyclo[3.2.1] octane-3-methanamine derivatives as ligands of D2 and D3 dopamine and 5HT1A and 5HT2 serotonin receptors |
| 04/24/2001 | US6221868 Remedies/preventives for frequent urination/urinary incontinence and tropone derivatives |
| 04/24/2001 | US6221660 Amino acid sequence; recombinant production; drug screening using membrane preparations |
| 04/24/2001 | US6221627 cDNA clone HDPB130 that encodes a novel human 7-transmembrane receptor |
| 04/24/2001 | US6221616 Detecting modulators of receptor binding protein; incubate cells with modulators and monitoring reduction in binding activity at receptor |
| 04/24/2001 | US6221613 Utilizing competitive binding to detect preferential modulator activity on receptor binding protein; incubate cells with modulators and monitor binding, detect amplification or reduction of binding to receptors |
| 04/24/2001 | CA2073166C Process to correct and optimize the composition of a feed |
| 04/24/2001 | CA2053277C Use of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
| 04/19/2001 | WO2001027622A1 Crystallographic structure of the androgen receptor ligand binding domain |
| 04/19/2001 | WO2001027147A1 A novel molecule |
| 04/19/2001 | WO2001027135A2 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 04/19/2001 | WO2001027131A1 Purine derivatives |
| 04/19/2001 | WO2001027130A1 Purine derivatives |
| 04/19/2001 | WO2001027113A2 PYRAZOLO `4,3-d! PYRIMIDINE DERIVATIVES |
| 04/19/2001 | WO2001027112A1 5-(2-substituted-5-heterocyclylsulphonylpyrid-3-yl)-dihydropyrazolo[4,3-d]pyrimidin-7-ones as phosphodiesterase inhibitors |
| 04/19/2001 | WO2001027105A1 Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof |
| 04/19/2001 | WO2001027101A2 Anhydrous salt |
| 04/19/2001 | WO2001027097A1 Polymorphic b form of 3-(cyclopropylmethoxy)-4-[4-(methylsulfonyl)phenyl]-5,5-dimethyl-5h-furan-2-one |
| 04/19/2001 | WO2001027086A1 Tetrahydroquinoline derivatives |
| 04/19/2001 | WO2001027079A2 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 04/19/2001 | WO2001027068A1 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 04/19/2001 | WO2001026664A2 Hormone-sensitive lipase activity mediated male infertility |
| 04/19/2001 | WO2001026644A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 04/19/2001 | WO2001026603A2 Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives |
| 04/19/2001 | WO2001014557B1 Pd-1, a receptor for b7-4, and uses therefor |
| 04/19/2001 | WO2001002565A3 Secreted protein zacrp4 |
| 04/19/2001 | WO2000071138A3 Oral administration of lactobacillus for the maintenance of health in women |
| 04/19/2001 | WO2000068380A3 Extracellular matrix and adhesion-associated proteins |
| 04/19/2001 | WO2000066129A3 Use of antiprogestagens in combined therapy |
| 04/19/2001 | WO2000066084A8 Aerosol formulations and devices for increasing libido in women via acute testosterone administration |
| 04/19/2001 | WO2000026245A3 Human membrane transport proteins |
| 04/19/2001 | WO2000012720A9 Elongase genes and uses thereof |
| 04/19/2001 | CA2388962A1 A molecular framework for amino acids or heterologous amino acid sequences |
| 04/19/2001 | CA2388253A1 Crystallographic structure of the androgen receptor ligand binding domain |
| 04/19/2001 | CA2387353A1 Pharmaceutically active compounds |
| 04/19/2001 | CA2387314A1 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 04/19/2001 | CA2383650A1 Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives |
| 04/19/2001 | CA2382937A1 Anhydrous salt |
| 04/18/2001 | EP1092719A2 Imidazo[5,1-f][1,2,4]triazine derivatives |
| 04/18/2001 | EP1092718A1 2-(2-Alkoxy-5-heterocyclylsulphonylphenyl)purin-6-ones as phosphodiesterase inhibitors |
| 04/18/2001 | EP1092717A2 Polycyclic azaindole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 04/18/2001 | EP1092431A2 Lasofoxifene compositions |
| 04/18/2001 | EP1091942A1 Potassium channel blocking agents |
| 04/18/2001 | EP0874815B1 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin d, methods for their production and pharmaceutical compositions thereof |
| 04/18/2001 | EP0771201B1 Use of 2-phenyl-3-aroylbenzothiophenes for the preparation of a medicament for inhibiting primary endometrial hyperplasia |
| 04/18/2001 | CN1291990A S-Substituted 11 & Beta-Benzaldoxime-estra-4, 9-diene-carbonic acid thiolesters, method for production thereof and pharmaceutical preparations containing these compounds |
| 04/18/2001 | CN1291894A Compositions comprising D-chiro-inositol for treating metabolic diseases characterized by hyperinsulinemia, hyperandrogenism, hyperlipidemia and/or anovulation |
| 04/18/2001 | CN1291889A Fluoxetine hydrochloride for decreasing hot flashes |
| 04/18/2001 | CN1291506A Exterior-applied medicine for preventing and treating mastopathy and its preparing process |
| 04/18/2001 | CN1291502A Chinese-medicinal pill for treating gynopathy |
| 04/18/2001 | CN1291491A Medicinal capsule for treating mastoplasia |
| 04/18/2001 | CN1064674C Alkoxyaryl compounds, their process of preparation and pharmaceutical compositions which contain them |
| 04/18/2001 | CN1064548C Capsule for promoting male sexual function and preparation process |
| 04/18/2001 | CN1064546C Capsule for treating pointed condyloma and preparation process |